Skip to content
Agentic OS
Menu

Intelligence / Healthtech / New Clinical Trials / CooperVision International Limited (CVIL)

Clinicaltrial registered16 Nov 2026

CooperVision International Limited (CVIL)

16 Nov 2026: Trial registered · Title: Clinical Performance and Outcomes After Sphere Lens Transition. Recorded in the ClinicalTrials.gov (US National Library of Medicine).

View the source record

Posted
16 Nov 2026
Title
Title: Clinical Performance and Outcomes After Sphere Lens Transition
Conditions
Astigmatism
Phase
Not applicable
Study Type
Interventional
Status
Not Yet Recruiting
Countries
Mexico
Country
Mexico
Reference
NCT07940426
Location
Mexico
What this signal means

A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.

  1. United States leads with 192 of 777, then China (171).
  2. 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at CooperVision International Limited (CVIL)

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.

Start free

Across AOS Research

Other records for CooperVision International Limited (CVIL) in our registers.

More from Mexico

New Clinical Trials

See all

Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.